据创鉴汇不完全统计,7月14日至7月20日全球生物制药领域共披露19起交易事件,潜在交易总额近7亿美元。上周超亿美元的交易集中于抗体及小分子药物,涉及癌症、中枢神经及眼科疾病等领域,反映了行业对这些高需求方向的持续投入。JCR公司与Acumen公司达成了一项潜在总额5.55亿美元的合作,共同开发阿尔茨海默病(AD)创新疗法。双方旨在利用JCR的血脑屏障穿透技术平台,将Acumen开发的选择性抗体...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.